Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Oligodendroglioma 1Myelodysplastic Syndromes 1Metastatic Castration-Resistant Prostate Cancer Patients 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Irinotecan 6Cyclophosphamide 4temsirolimus 2Sirolimus 2Filgrastim 2Early Intervention, Educational 2Carboplatin 2sargramostim 1reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Thalidomide 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Immunologic Techniques 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Unspecified Childhood Solid Tumor, Protocol Specific × irofulven × Clear all
NCT00003370 2013-02-05

Irofulven in Treating Children With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡